EUVIMEDEUVIMED entdecken
Crossref

Empagliflozin alleviates neuroinflammation by inhibiting astrocyte activation in the brain and regulating gut microbiota of high-fat diet mice

Qiaoyan Huang, Liu Liu, Xiaoyao Tan, Shitong Wang, Sichen Wang, Jun Luo, Jiayi Chen, Na Yang, Jiajun Jiang, Yiming Liu, Xiao Hong, Shunyuan Guo und 7 weitere

Journal of Affective Disorders · 2024

DOI: 10.1016/j.jad.2024.05.150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Qiaoyan Huang und 18 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diet, High-Fat, Astrocytes, Glucosides. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A high-fat diet can modify the composition of gut microbiota, resulting in dysbiosis. Changes in gut microbiota composition can lead to increased permeability of the gut barrier, allowing bacterial products like lipopolysaccharides (LPS) to enter circulation. This process can initiate systemic inflammation and contribute to neuroinflammation. Empagliflozin (EF), an SGLT2 inhibitor-type hypoglycemic drug, has been reported to treat neuroinflammation. However, there is a lack of evidence showing that EF regulates the gut microbiota axis to control neuroinflammation in HFD models. In this study, we explored whether EF could improve neuroinflammation caused by an HFD via regulation of the gut microbiota and the mechanism underlying this phenomenon. Our data revealed that EF alleviates pathological brain injury, reduces the reactive proliferation of astrocytes, and increases the expression of synaptophysin. In addition, the levels of inflammatory factors in hippocampal tissue were significantly decreased after EF intervention. Subsequently, the results of 16S rRNA gene sequencing showed that EF could change the microbial community structure of mice, indicating that the abundance of Lactococcus, Ligilactobacillus and other microbial populations decreased dramatically. Therefore, EF alleviates neuroinflammation by inhibiting gut microbiota-mediated astrocyte activation in the brains of high-fat diet-fed mice. Our study focused on the gut-brain axis, and broader research on neuroinflammation can provide a more holistic understanding of the mechanisms driving neurodegenerative diseases and inform the development of effective strategies to mitigate their impact on brain health. The results provide strong evidence supporting the larger clinical application of EF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDiet, High-FatAstrocytesGlucosidesBenzhydryl CompoundsNeuroinflammatory DiseasesAnimalsMiceMaleMice, Inbred C57BLBrainBrain-Gut AxisDisease Models, AnimalSodium-Glucose Transporter 2 InhibitorsHippocampusDysbiosis

Stichwörter der Autor:innen

EmpagliflozinMicrobiota-gut-brain axisMultiomic analysisNeuroinflammation

Substanzen

GlucosidesempagliflozinBenzhydryl CompoundsSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • Collaborative Innovation Center of Seafood Deep Processing, Zhejiang Province Joint Key Laboratory of Aquatic Products Processing, Institute of Seafood, Zhejiang Gongshang University, Hangzhou, China.
  • Center for Rehabilitation Medicine, Department of Neurology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou 314408, China.
  • Hangzhou Linping Hospital of Traditional Chinese Medicine, Linping 311106, China.
  • Collaborative Innovation Center of Seafood Deep Processing, Zhejiang Province Joint Key Laboratory of Aquatic Products Processing, Institute of Seafood, Zhejiang Gongshang University, Hangzhou, China. Electronic address…
  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China; Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: lcyzc…

Zitieren

APA

Huang, Q., Liu, L., Tan, X., Wang, S., Wang, S., Luo, J., Chen, J., Yang, N., Jiang, J., Liu, Y., Hong, X., Guo, S., Shen, Y., Gao, F., Feng, H., Zhang, J., Shen, Q., Li, C., & Ji, L. (2024). Empagliflozin alleviates neuroinflammation by inhibiting astrocyte activation in the brain and regulating gut microbiota of high-fat diet mice. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.05.150

Vancouver

Huang Q, Liu L, Tan X, Wang S, Wang S, Luo J, et al. Empagliflozin alleviates neuroinflammation by inhibiting astrocyte activation in the brain and regulating gut microbiota of high-fat diet mice. Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.05.150

BibTeX
@article{Huang2024,
  author = {Huang, Qiaoyan and Liu, Liu and Tan, Xiaoyao and Wang, Shitong and Wang, Sichen and Luo, Jun and Chen, Jiayi and Yang, Na and Jiang, Jiajun and Liu, Yiming and Hong, Xiao and Guo, Shunyuan and Shen, Yuejian and Gao, Feng and Feng, Huina and Zhang, Jianliang and Shen, Qing and Li, Changyu and Ji, Liting},
  title = {Empagliflozin alleviates neuroinflammation by inhibiting astrocyte activation in the brain and regulating gut microbiota of high-fat diet mice},
  journal = {Journal of Affective Disorders},
  year = {2024},
  doi = {10.1016/j.jad.2024.05.150}
}
Kostenlos starten →